Rocket


News + Filings
Transactions





Lubner David Charles

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/14/2023Arcellx, Inc. GrantStock Option (right to buy)11.5k$37.94$434.8k 06/14/2023
06/01/2023POINT Biopharma Global Inc.PNTGrantStock Option (Right to Buy)44.7k$9.12$408.1k 06/01/2023
05/26/2023Vor Biopharma Inc. GrantStock Option (right to buy)30k$4.79$143.7k 05/26/2023
05/24/2023Dyne Therapeutics, Inc. GrantStock Option (right to buy)24.9k$13.49$335.9k 05/24/2023
11/23/2022POINT Biopharma Global Inc.PNTPurchaseCommon Stock3.6k$6.85$24.7k 11/23/2022
07/05/2022Dyne Therapeutics, Inc. GrantStock Option (right to buy)7.2k$5.54$40k 07/05/2022
06/14/2022Vor Biopharma Inc. GrantStock Option (right to buy)16.9k$4.26$72k 06/14/2022
06/03/2022Dyne Therapeutics, Inc. GrantStock Option (right to buy)19.6k$4.58$89.7k 06/03/2022
06/02/2022POINT Biopharma Global Inc.PNTGrantStock Option (Right to Buy)25.6k$8.31$212.9k 06/02/2022
02/08/2022Arcellx, Inc. ConversionCommon Stock21.7k$0.00$0 02/08/2022
02/08/2022Arcellx, Inc. ConversionSeries C Preferred Stock21.7k$0.00$0 02/08/2022
02/03/2022Arcellx, Inc. GrantStock Option (right to buy)61.5k$15.00$923.1k 02/03/2022
10/04/2021Disc Medicine, Inc. GrantStock Option (Right to Buy)0$0.00$0 10/04/2021
10/04/2021Disc Medicine, Inc. GrantStock Option (Right to Buy)17.2k$3.80$65.5k 10/04/2021
07/06/2021POINT Biopharma Global Inc.PNTGrantStock Option (Right to Buy)25k$8.47$211.8k 07/06/2021
05/26/2021Dyne Therapeutics, Inc. GrantStock Option (right to buy)19.6k$19.56$383.3k 05/26/2021
03/12/2021Disc Medicine, Inc. GrantStock Option (Right to Buy)17.5k$17.00$298k 03/12/2021
03/12/2021Disc Medicine, Inc. GrantStock Option (Right to Buy)25k$17.00$425k 03/12/2021
02/05/2021Disc Medicine, Inc. GrantStock Option (Right to Buy)58.9k$12.66$745.1k 03/12/2021
02/05/2021Vor Biopharma Inc. GrantStock Option (right to buy)16.9k$18.00$304.2k 02/05/2021
09/21/2020Dyne Therapeutics, Inc. ConversionSeries B Preferred Stock177.9k$0.00$0 07/31/2020
09/21/2020Dyne Therapeutics, Inc. ConversionCommon Stock53.6k$0.00$0 07/31/2020
08/07/2020Dyne Therapeutics, Inc. PurchaseSeries B Preferred Stock177.9k$2.81$500k 07/31/2020
07/31/2020Dyne Therapeutics, Inc. GrantStock Option (right to buy)11.2k$5.54$61.8k 07/31/2020
07/31/2020Dyne Therapeutics, Inc. GrantStock Option (right to buy)14.4k$5.54$80k 07/31/2020
04/02/2020Ra Pharmaceuticals, Inc.RARXDispositionCommon Stock15.6k$48.00$749.9k 04/02/2020
04/02/2020Ra Pharmaceuticals, Inc.RARXDispositionStock Option (Right to Buy)115.6k$2.87$331.7k 04/02/2020
04/02/2020Ra Pharmaceuticals, Inc.RARXDispositionStock Option (Right to Buy)92.3k$2.87$264.9k 04/02/2020
04/02/2020Ra Pharmaceuticals, Inc.RARXDispositionStock Option (Right to Buy)28.6k$5.60$160k 04/02/2020
04/02/2020Ra Pharmaceuticals, Inc.RARXDispositionStock Option (Right to Buy)112.5k$16.64$1.9M 04/02/2020
04/02/2020Ra Pharmaceuticals, Inc.RARXDispositionStock Option (Right to Buy)62.5k$7.33$458.1k 04/02/2020
04/02/2020Ra Pharmaceuticals, Inc.RARXDispositionStock Option (Right to Buy)133k$21.00$2.8M 04/02/2020
04/02/2020Ra Pharmaceuticals, Inc.RARXDispositionRestricted Stock Units10.4k$0.00$0 04/02/2020
06/07/2019Nightstar Therapeutics LtdNITEDispositionStock Option (Right to Buy)21k$13.57$285k 06/07/2019
06/07/2019Nightstar Therapeutics LtdNITEDispositionStock Option (Right to Buy)18.2k$12.27$223.3k 06/07/2019
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy